University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania
Dr. Hernando Gomez is an Associate professor of Critical Care Medicine, at the University of Pittsburgh. Dr. Gomez is a trained anesthesiologist and intensivist, who dedicates his practice to the care of critically ill patients in the Cardiothoracic intensive care unit at Presbyterian Hospital of the University of Pittsbiurgh Medical Center (UPMC). Dr. Gomez also completed a Masters in Public Health at the University of Pittsburgh. From an educational stand point, Dr. Gomez is the asociate director of the Anesthesia Critical Care fellowship training program at the University of Pittsburgh, and the director of the Advanced Physiology course provided to the critical care fellows in training. In addition to a clinician and educator, Dr. Gomez is also a translational researcher. The primary goal of his research is to understand the fundamental mechanisms by which sepsis and shock induce organ dysfunction. Specifically, his focus is on the role of energy regulatory pathways and microvascular dysfunction in the origin of sepsis-induced organ dysfunction. Dr. Gomez has been funded by the NIH at the K08 level, and has had multiple foundation and industry grants to develop his research. Currently, he is funded in the capacity of Co-investigator through a grant with the Department of Defense of the United States developing close loop algorythms for hemodynamic resuscitation of patients in austere environments. Dr. Gomez is currently the site Principal investigator (PI) for two, industry-funded multicenter randomized clinical trials, served as the global PI for the LAPIS trial, a multicenter, multicontinental study in sepsis associated acute kidney injury, and is currently a core member of the Pittsburgh Sepsis Trialist committee created in 2016. Dr. Gomez has published 51 peer reviewed manuscripts, more than twenty book chapters, two books and multiple abstracts.
Friday, January 20, 2023
8:00 AM – 5:00 PM PT
Disclosure(s): AMPharma: Clinical Trial Investigator (Ongoing); Baxter: Grant/Research Support (Ongoing); bioMerieux: Clinical Trial Investigator (Ongoing), Grant/Research Support (Ongoing); Novartis: Advisory Board (Ongoing), Consultant (Ongoing); Trilinear: Advisory Board (Ongoing), Consultant (Ongoing)
Friday, January 20, 2023
1:00 PM – 1:30 PM PT
Disclosure(s): AMPharma: Clinical Trial Investigator (Ongoing); Baxter: Grant/Research Support (Ongoing); bioMerieux: Clinical Trial Investigator (Ongoing), Grant/Research Support (Ongoing); Novartis: Advisory Board (Ongoing), Consultant (Ongoing); Trilinear: Advisory Board (Ongoing), Consultant (Ongoing)